Maternal and neonatal outcomes and clinical laboratory testing of pregnant women with COVID-19 during the BA.5.2/BF.7 surge

References

• Harris E. WHO declares end of COVID-19 global health emergency. JAMA. 2023 Jun 6;329(21):1817. doi: 10.1001/jama.2023.8656 PubMed PMID: 37195734.
   Web of Science ®Google Scholar
• Wise J. Covid-19: WHO declares end of global health emergency. BMJ. 2023 May 9;381:1041. doi: 10.1136/bmj.p1041 PubMed PMID: 37160309.
   PubMedGoogle Scholar
• Margerison CE, Wang X, Gemmill A, et al. Changes in pregnancy-associated deaths in the US during the COVID-19 pandemic in 2020. JAMA Netw Open. 2023 Feb 1;6(2):e2254287. doi: 10.1001/jamanetworkopen.2022.54287 PubMed PMID: 36723945; PubMed Central PMCID: PMCPMC9892955.
   PubMed Web of Science ®Google Scholar
• Shukla VV, Rahman AF, Shen X, et al. Trends in maternal outcomes during the COVID-19 pandemic in Alabama from 2016 to 2021. JAMA Netw Open. 2022 Apr 1;5(4):e222681. doi: 10.1001/jamanetworkopen.2022.2681 PubMed PMID: 35416995; PubMed Central PMCID: PMCPMC9008492 stocks outside the submitted work. No other disclosures were reported.
   PubMed Web of Science ®Google Scholar
• Villar J, Soto Conti CP, Gunier RB, et al. Pregnancy outcomes and vaccine effectiveness during the period of omicron as the variant of concern, INTERCOVID-2022: a multinational, observational study. Lancet. 2023 Feb 11;401(10375):447–12. doi: 10.1016/S0140-6736(22)02467-9 PubMed PMID: 36669520; PubMed Central PMCID: PMCPMC9910845 Pharmaceuticals and has received payment in the past for presentations and educational events from Bayer, GlaxoSmithKline, Ferring Pharmaceuticals, and Sigvaris. BMdT received a research grant from the General Health Direction of Geneva, has participated on an advisory board of Effik and Pierre Favre, and has received medical equipment from Pregnolia, Hologic, and PeriLynx. All other authors declare no competing interests.
   PubMed Web of Science ®Google Scholar
• Tegally H, Moir M, Everatt J, et al. Emergence of SARS-CoV-2 Omicron lineages BA.4 and BA.5 in South Africa. Nat Med. 2022 Sep;28(9):1785–1790. doi: 10.1038/s41591-022-01911-2 PubMed PMID: 35760080; PubMed Central PMCID: PMCPMC9499863 Lancet Laboratories.
   PubMed Web of Science ®Google Scholar
• Kimura I, Yamasoba D, Tamura T, et al. Virological characteristics of the SARS-CoV-2 Omicron BA.2 subvariants, including BA.4 and BA.5. Cell. 2022 Oct 13;185(21):3992–4007 e16. doi: 10.1016/j.cell.2022.09.018 PubMed PMID: 36198317; PubMed Central PMCID: PMCPMC9472642.
   PubMed Web of Science ®Google Scholar
• Tamura T, Yamasoba D, Oda Y, et al. Comparative pathogenicity of SARS-CoV-2 Omicron subvariants including BA.1, BA.2, and BA.5. Commun Biol. 2023 Jul 24;6(1):772. doi: 10.1038/s42003-023-05081-w PubMed PMID: 37488344; PubMed Central PMCID: PMCPMC10366110 of HiLung, Inc. Y.Y. is a co-inventor of a patent (PCT/JP2016/057254, “Method for inducing differentiation of alveolar epithelial cells”) related to this work. I.Y. reports speaker fees from Chugai Pharmaceutical Co, and AstraZeneca plt, outside the submitted work. The other authors declare no competing interests.
   PubMed Web of Science ®Google Scholar
• Ou S, Huang Z, Lan M, et al. The duration and breadth of antibody responses to 3-dose of inactivated COVID-19 vaccinations in healthy blood donors: An observational study. Front Immunol. 2022;13:1027924. doi: 10.3389/fimmu.2022.1027924 PubMed PMID: 36389837; PubMed Central PMCID: PMCPMC9663651.
   PubMed Web of Science ®Google Scholar
• Chen S, Huang Z, Guo Y, et al. Evolving spike mutations in SARS-CoV-2 Omicron variants facilitate evasion from breakthrough infection-acquired antibodies. Cell Discov. 2023 Aug 18;9(1):86. doi: 10.1038/s41421-023-00584-6 PubMed PMID: 37596249; PubMed Central PMCID: PMCPMC10439137.
   PubMed Web of Science ®Google Scholar
• Lee SW. Methods for testing statistical differences between groups in medical research: statistical standard and guideline of life cycle committee. Life Cycle. 2022;2:e1. doi: 10.54724/lc.2022.e1
   Google Scholar
• Alon R, Sportiello M, Kozlovski S, et al. Leukocyte trafficking to the lungs and beyond: lessons from influenza for COVID-19. Nat Rev Immunol. 2021 Jan;21(1):49–64. doi: 10.1038/s41577-020-00470-2 PubMed PMID: 33214719; PubMed Central PMCID: PMCPMC7675406.
   PubMed Web of Science ®Google Scholar
• Levi M, Thachil J, Iba T, et al. Coagulation abnormalities and thrombosis in patients with COVID-19. Lancet Haematol. 2020 Jun;7(6):e438–e440. doi: 10.1016/S2352-3026(20)30145-9 PubMed PMID: 32407672; PubMed Central PMCID: PMCPMC7213964.
   PubMed Web of Science ®Google Scholar
• Connors JM, Levy JH. COVID-19 and its implications for thrombosis and anticoagulation. Blood. 2020 Jun 4;135(23):2033–2040. doi: 10.1182/blood.2020006000 PubMed PMID: 32339221; PubMed Central PMCID: PMCPMC7273827.
   PubMed Web of Science ®Google Scholar
• Smith ER, Oakley E, Grandner GW, et al. Clinical risk factors of adverse outcomes among women with COVID-19 in the pregnancy and postpartum period: a sequential, prospective meta-analysis. Am J Obstet Gynecol. 2023 Feb;228(2):161–177. doi: 10.1016/j.ajog.2022.08.038 PubMed PMID: 36027953; PubMed Central PMCID: PMCPMC9398561.
   PubMed Web of Science ®Google Scholar
• Chmielewska B, Barratt I, Townsend R, et al. Effects of the COVID-19 pandemic on maternal and perinatal outcomes: a systematic review and meta-analysis. Lancet Glob Health. 2021 Jun;9(6):e759–e772. doi: 10.1016/S2214-109X(21)00079-6 PubMed PMID: 33811827; PubMed Central PMCID: PMCPMC8012052.
   PubMed Web of Science ®Google Scholar
• Ahlberg M, Neovius M, Saltvedt S, et al. Association of SARS-CoV-2 test status and pregnancy outcomes. JAMA. 2020 Nov 3;324(17):1782–1785. doi: 10.1001/jama.2020.19124 PubMed PMID: 32965467; PubMed Central PMCID: PMCPMC7512127.
   PubMed Web of Science ®Google Scholar
• Woodworth KR, Olsen EO, Neelam V, et al. Birth and infant outcomes following laboratory-confirmed SARS-CoV-2 Infection in Pregnancy - SET-NET, 16 jurisdictions, March 29-October 14, 2020. MMWR Morb Mortal Wkly Rep. 2020 Nov 6;69(44):1635–1640. doi: 10.15585/mmwr.mm6944e2 PubMed PMID: 33151917; PubMed Central PMCID: PMCPMC7643898 Journal Editors form for disclosure of potential conflicts of interest. No potential conflicts of interest were disclosed.
   PubMed Web of Science ®Google Scholar
• Wei SQ, Bilodeau-Bertrand M, Liu S, et al. The impact of COVID-19 on pregnancy outcomes: a systematic review and meta-analysis. CMAJ. 2021 Apr 19;193(16):E540–E548. doi: 10.1503/cmaj.202604 PubMed PMID: 33741725; PubMed Central PMCID: PMCPMC8084555.
   PubMed Web of Science ®Google Scholar
• McClymont E, Albert AY, Alton GD, et al. Association of SARS-CoV-2 infection during pregnancy with maternal and perinatal outcomes. JAMA. 2022 May 24;327(20):1983–1991. doi: 10.1001/jama.2022.5906 PubMed PMID: 35499852; PubMed Central PMCID: PMCPMC9062768 from a Michael Smith Foundation for Health Research Trainee Award and a Canadian HIV Trials Network Postdoc Fellowship. Dr Boucoiran reported receiving grants from Fonds de Recherche en Sante du Quebec, Ferring, and the Quebec Health Ministry; receiving personal fees from Fonds de Recherche en Sante du Quebec; receiving nonfinancial support from Altona; and participating in randomized clinical trials for GlaxoSmithKline and Pfizer. Dr Poliquin reported receiving honoraria/consultation fees from GlaxoSmithKline, Sanofi Pasteur, and Searchlight Pharma. Dr Sprague reported receiving funding from the Ontario Ministry of Health for BORN Ontario. Dr Elwood reported receipt of personal fees for board membership from Gilead. Dr Money reported receiving nonfinancial support from the COVID-19 Immunity Task Force and grants from the Canadian Institutes for Health Research (outside the submitted work), Merck, GlaxoSmithKline, Sanofi, and Novartis. No other disclosures were reported.
   PubMed Web of Science ®Google Scholar
• Xi C, Yan Z, Bai D, et al. Immune rebalancing at the maternal-fetal interface of maternal SARS-CoV-2 infection during early pregnancy. Protein & Cell. 2024 Mar 5. doi: 10.1093/procel/pwae006 PubMed PMID: 38441496.
   PubMed Web of Science ®Google Scholar
• Garcia-Flores V, Romero R, Xu Y, et al. Maternal-fetal immune responses in pregnant women infected with SARS-CoV-2. Nat Commun. 2022 Jan 18;13(1):320. doi: 10.1038/s41467-021-27745-z PubMed PMID: 35042863; PubMed Central PMCID: PMCPMC8766450.
   PubMed Web of Science ®Google Scholar
• Holt PG, Strickland DH, Wikstrom ME, et al. Regulation of immunological homeostasis in the respiratory tract. Nat Rev Immunol. 2008 Feb;8(2):142–152. doi: 10.1038/nri2236 PubMed PMID: 18204469.
   PubMed Web of Science ®Google Scholar
• Tavakolpour S, Rakhshandehroo T, Wei EX, et al. Lymphopenia during the COVID-19 infection: What it shows and what can be learned. Immunol Lett. 2020 Sep;225:31–32. doi: 10.1016/j.imlet.2020.06.013 PubMed PMID: 32569607; PubMed Central PMCID: PMCPMC7305732.
   PubMed Web of Science ®Google Scholar
• Chen Z, John Wherry E. T cell responses in patients with COVID-19. Nat Rev Immunol. 2020 Sep;20(9):529–536. doi: 10.1038/s41577-020-0402-6 PubMed PMID: 32728222; PubMed Central PMCID: PMCPMC7389156 Roche, Pieris, Elstar and Surface Oncology. E.J.W. has a patent licensing agreement on the PD1 pathway with Roche/Genentech. E.J.W. is a founder of Arsenal Biosciences. Z.C. declares no competing interests.
   PubMed Web of Science ®Google Scholar
• Giamarellos-Bourboulis EJ, Netea MG, Rovina N, et al. Complex immune dysregulation in COVID-19 patients with severe respiratory failure. Cell Host Microbe. 2020 Jun 10;27(6):992–1000 e3. doi: 10.1016/j.chom.2020.04.009 PubMed PMID: 32320677; PubMed Central PMCID: PMCPMC7172841.
   PubMed Web of Science ®Google Scholar
• Hamada H, Garcia-Hernandez Mde L, Reome JB, et al. Tc17, a unique subset of CD8 T cells that can protect against lethal influenza challenge. J Immunol. 2009 Mar 15;182(6):3469–3481. doi: 10.4049/jimmunol.0801814 PubMed PMID: 19265125; PubMed Central PMCID: PMCPMC2667713.
   PubMed Web of Science ®Google Scholar
• Saito S, Nakashima A, Shima T, et al. REVIEW ARTICLE: Th1/Th2/Th17 and Regulatory T-Cell Paradigm in Pregnancy. Am J Reprod Immunol. 2010 Jun;63(6):601–610. doi: 10.1111/j.1600-0897.2010.00852.x PubMed PMID: 20455873.
   PubMed Web of Science ®Google Scholar
• PrabhuDas M, Bonney E, Caron K, et al. Immune mechanisms at the maternal-fetal interface: perspectives and challenges. Nat Immunol. 2015 Apr;16(4):328–334. doi: 10.1038/ni.3131 PubMed PMID: 25789673; PubMed Central PMCID: PMCPMC5070970.
   PubMed Web of Science ®Google Scholar
• Miller D, Gershater M, Slutsky R, et al. Maternal and fetal T cells in term pregnancy and preterm labor. Cell Mol Immunol. 2020 Jul;17(7):693–704. doi: 10.1038/s41423-020-0471-2 PubMed PMID: 32467619; PubMed Central PMCID: PMCPMC7331691.
   PubMed Web of Science ®Google Scholar
• Kim M, Choi Y, Lee M, et al. Maternal SARS-CoV-2 infection during pregnancy and subsequent risk of atopic dermatitis in offspring: a nationwide birth cohort study in South Korea. Br J Dermatol. 2024 Mar 15;190(4):576–577. doi: 10.1093/bjd/ljad478 PubMed PMID: 38035775.
   PubMed Web of Science ®Google Scholar
• Han H, Yang L, Liu R, et al. Prominent changes in blood coagulation of patients with SARS-CoV-2 infection. Clin Chem Lab Med. [2020 Jun 25];58(7):1116–1120. doi: 10.1515/cclm-2020-0188 PubMed PMID: 32172226.
   PubMed Web of Science ®Google Scholar
• Hadid T, Kafri Z, Al-Katib A. Coagulation and anticoagulation in COVID-19. Blood Rev. 2021 May;47:100761. doi: 10.1016/j.blre.2020.100761 PubMed PMID: 33067035; PubMed Central PMCID: PMCPMC7543932.
   PubMed Web of Science ®Google Scholar
• Devreese KMJ. COVID-19-related laboratory coagulation findings. Int J Lab Hematol. 2021 Jul;43 Suppl 1(Suppl 1):36–42. doi: 10.1111/ijlh.13547 PubMed PMID: 34288440; PubMed Central PMCID: PMCPMC8444785.
   PubMedGoogle Scholar
• In China, the proportion of individuals fully vaccinated against COVID-19 reaches 88.01%. People’s Daily. 2022 [cited 2023 Oct 28]. Available from: https://www.gov.cn/xinwen/2022-03/26/content_5681691.htm
   Google Scholar
• Mathieu E, Ritchie H, Ortiz-Ospina E, et al. A global database of COVID-19 vaccinations. Nat Hum Behav. 2021 Jul;5(7):947–953. doi: 10.1038/s41562-021-01122-8 PubMed PMID: 33972767.
   PubMed Web of Science ®Google Scholar
• Zhang Y, Huang Z, Zhuang S, et al. Effectiveness of first and second boost COVID-19 vaccination in healthy adults during BA.5.2/BF.7 surge in China. Hum Vaccin Immunother. 2023 Aug 1;19(2):2246483. doi: 10.1080/21645515.2023.2246483 PubMed PMID: 37674298; PubMed Central PMCID: PMCPMC10486280.
   PubMed Web of Science ®Google Scholar